Ulixacaltamide (developmental codes PRAX-944 and Z-944) is an investigational new drug developed by Praxis Precision Medicines for the treatment of essential tremor (ET).
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.